LB42908 is a potent, selective and orally active farnesyltransferase inhibitor. LB42908 inhibits farnesylation of H-Ras , K-Ras with IC 50 values of 0.9 nM, 2.4 nM for H-Ras , K-Ras , respectively. LB42908 shows antiproliferative activity. LB42908 shows antitumor activity.
Products | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Signaling Pathways > Farnesyl Transferase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.